+958.0%
MRNA vs SM
+61.3%
+896.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -5.3% | +0.5% | -4.8% |
| 7D | -20.9% | -7.5% | -13.4% | -20.8% |
| 30D | -13.3% | -25.9% | +12.6% | -13.0% |
| 3M | +212.6% | -18.3% | +230.9% | +212.9% |
| 6M | +309.0% | -12.0% | +321.0% | +308.5% |
| YTD | +567.3% | +57.4% | +509.9% | +557.2% |
| 1Y | +689.7% | +55.8% | +633.9% | +677.8% |
| 3Y | +157.4% | -17.7% | +175.1% | +155.3% |
| 5Y | -21.7% | -3.2% | -18.6% | -21.7% |
| All | +958.0% | +61.3% | +896.7% | +1,294.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SM.
Daily Out/Under-Performance
Portfolio return minus SM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling